Crossmark

Efficacy of the combination use of aprepitant and palonosetron for improving nausea in various moderately emetogenic chemotherapy regimens

Crossref DOI link: https://doi.org/10.1186/s40360-018-0278-2

Published Online: 2019-01-14

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yoshida, Naohisa http://orcid.org/0000-0001-6167-9705
Taguchi, Tetsuya

Nakanishi, Masayoshi

Inoue, Ken

Okayama, Tetsuya

Ishikawa, Takeshi

Otsuji, Eigo

Takayama, Koichi

Kuroboshi, Haruo

Kanazawa, Motohiro

Itoh, Yoshito
License Information

Text and Data Mining valid from 2019-01-14
More Information

Article History

Received: 29 August 2018

Accepted: 6 December 2018

First Online: 14 January 2019

Ethics approval and consent to participate

: This study was approved by the ethics committee of Kyoto Prefectural University of Medicine and was carried out in accordance with the World Medical Association Helsinki Declaration (adopted in 1964 and amended in 1975, 1983, 1989, 1996, 2000, 2002, 2004, and 2008). This manuscript has not been published or submitted for publication elsewhere. All authors have participated in this manuscript.

: Not applicable.

: All authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.